International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.13333468
Original Research Article
Do Age and Pirani Score Influence Management of Club Foot by Ponseti Method
Published
Nov. 7, 2024
Abstract

Background: The Ponseti method is a widely accepted treatment for clubfoot. This study aimed to evaluate the role of age and Pirani score in the management of clubfoot using the Ponseti method.Methods: A prospective hospital-based study was conducted on 35 patients with idiopathic clubfoot treated using the Ponseti method. The patients were assessed based on age at presentation and initial Pirani score. The primary outcomes were the number of casts required for correction, duration of treatment, and final Pirani score.Results: The mean age at presentation was 1.8 ± 1.2 months, with 83% of patients presenting before 2 months of age. The mean initial Pirani score was 4.84 ± 1.46. The mean number of casts required for correction was 6.2 ± 1.4. The mean final Pirani score was 0.13, showing a significant improvement from the initial score (p<0.001). Patients presenting before 2 months of age had better outcomes, with a mean final Pirani score of 0.14 compared to 0.1 in the 3-4 months age group and 0 in the 5-6 months age group.Conclusion: The Ponseti method is an effective treatment for clubfoot, with better outcomes observed in patients presenting at a younger age. The Pirani score is a useful tool for assessing the severity of clubfoot and monitoring treatment progress

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
630 Views
106 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved